Bank of America’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.54M | Buy |
270,220
+898
| +0.3% | +$28.4K | ﹤0.01% | 2877 |
|
|
2025
Q1 | $8.94M | Buy |
269,322
+66,814
| +33% | +$2.22M | ﹤0.01% | 2761 |
|
|
2024
Q4 | $6.97M | Sell |
202,508
-113,458
| -36% | -$3.9M | ﹤0.01% | 2776 |
|
|
2024
Q3 | $12.6M | Buy |
315,966
+32,635
| +12% | +$1.31M | ﹤0.01% | 2450 |
|
|
2024
Q2 | $8.55M | Buy |
283,331
+209,525
| +284% | +$6.32M | ﹤0.01% | 2669 |
|
|
2024
Q1 | $2.48M | Buy |
73,806
+39,461
| +115% | +$1.33M | ﹤0.01% | 3608 |
|
|
2023
Q4 | $1.11M | Sell |
34,345
-21,259
| -38% | -$687K | ﹤0.01% | 4062 |
|
|
2023
Q3 | $1.82M | Buy |
55,604
+31,339
| +129% | +$1.03M | ﹤0.01% | 3622 |
|
|
2023
Q2 | $854K | Sell |
24,265
-24,949
| -51% | -$878K | ﹤0.01% | 4131 |
|
|
2023
Q1 | $1.61M | Buy |
49,214
+3,193
| +7% | +$104K | ﹤0.01% | 3867 |
|
|
2022
Q4 | $2.54M | Buy |
46,021
+1,013
| +2% | +$55.8K | ﹤0.01% | 3484 |
|
|
2022
Q3 | $1.99M | Buy |
45,008
+13,044
| +41% | +$578K | ﹤0.01% | 3657 |
|
|
2022
Q2 | $1.56M | Buy |
31,964
+4,344
| +16% | +$212K | ﹤0.01% | 3897 |
|
|
2022
Q1 | $1.34M | Sell |
27,620
-9,406
| -25% | -$457K | ﹤0.01% | 4315 |
|
|
2021
Q4 | $1.58M | Buy |
37,026
+21,461
| +138% | +$915K | ﹤0.01% | 4113 |
|
|
2021
Q3 | $597K | Buy |
15,565
+10,095
| +185% | +$387K | ﹤0.01% | 4727 |
|
|
2021
Q2 | $155K | Sell |
5,470
-4,327
| -44% | -$123K | ﹤0.01% | 5483 |
|
|
2021
Q1 | $324K | Buy |
9,797
+8,203
| +515% | +$271K | ﹤0.01% | 5064 |
|
|
2020
Q4 | $58K | Buy |
1,594
+1,562
| +4,881% | +$56.8K | ﹤0.01% | 5508 |
|
|
2020
Q3 | $1K | Buy |
+32
| New | +$1K | ﹤0.01% | 6093 |
|